mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.05 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.05 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
embelin |
GDSC1000 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.06 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |